18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

ALK 0 3 25 28 O
- 3 4 28 29 O
positive 4 12 29 37 O
NSCLC 13 18 38 43 B-cancer
patients 19 27 44 52 O
with 28 32 53 57 O
asymptomatic 33 45 58 70 O
central 46 53 71 78 B-cancer
nervous 54 61 79 86 I-cancer
system 62 68 87 93 I-cancer
( 69 70 94 95 I-cancer
CNS 70 73 95 98 I-cancer
) 73 74 98 99 I-cancer
metastases 75 85 100 110 I-cancer
who 86 89 111 114 O
are 90 93 115 118 O
neurologically 94 108 119 133 O
stable 109 115 134 140 O
or 116 118 141 143 O
have 119 123 144 148 O
not 124 127 149 152 O
required 128 136 153 161 O
increasing 137 147 162 172 O
doses 148 153 173 178 O
of 154 156 179 181 O
steroids 157 165 182 190 B-treatment
within 166 172 191 197 O
the 173 176 198 201 O
2 177 178 202 203 B-upper_bound
week 179 183 204 208 I-upper_bound
prior 184 189 209 214 I-upper_bound
to 190 192 215 217 O
study 193 198 218 223 O
entry 199 204 224 229 O
to 205 207 230 232 O
manage 208 214 233 239 O
CNS 215 218 240 243 O
symptoms 219 227 244 252 O

Able 0 4 253 257 O
to 5 7 258 260 O
swallow 8 15 261 268 O
oral 16 20 269 273 B-treatment
medications 21 32 274 285 I-treatment

Absolute 0 8 286 294 B-clinical_variable
Neutrophil 9 19 295 305 I-clinical_variable
Count 20 25 306 311 I-clinical_variable
( 26 27 312 313 I-clinical_variable
ANC 27 30 313 316 I-clinical_variable
) 30 31 316 317 I-clinical_variable
> 32 33 318 319 O
/= 33 35 319 321 O
1,500 36 41 322 327 B-lower_bound
/ 41 42 327 328 I-lower_bound
microliter 42 52 328 338 I-lower_bound
; 52 53 338 339 O
Platelets 54 63 340 349 B-clinical_variable
> 64 65 350 351 O
/= 65 67 351 353 O
100,000 68 75 354 361 B-lower_bound
/ 75 76 361 362 I-lower_bound
microliter 76 86 362 372 I-lower_bound
; 86 87 372 373 O
Hemoglobin 88 98 374 384 B-clinical_variable
( 99 100 385 386 I-clinical_variable
Hgb 100 103 386 389 I-clinical_variable
) 103 104 389 390 I-clinical_variable
> 105 106 391 392 O
/= 106 108 392 394 O
9 109 110 395 396 B-lower_bound
g 111 112 397 398 I-lower_bound
/ 112 113 398 399 I-lower_bound
dL 113 115 399 401 I-lower_bound
; 115 116 401 402 O
Creatinine 117 127 403 413 B-clinical_variable
< 128 129 414 415 O
/= 129 131 415 417 O
1.5 132 135 418 421 B-upper_bound
X 136 137 422 423 I-upper_bound
upper 138 143 424 429 I-upper_bound
limit 144 149 430 435 I-upper_bound
of 150 152 436 438 I-upper_bound
normal 153 159 439 445 I-upper_bound
( 160 161 446 447 I-upper_bound
ULN 161 164 447 450 I-upper_bound
) 164 165 450 451 I-upper_bound
; 165 166 451 452 O
Prothrombin 167 178 453 464 B-clinical_variable
Time 179 183 465 469 I-clinical_variable
( 184 185 470 471 I-clinical_variable
PT 185 187 471 473 I-clinical_variable
) 187 188 473 474 I-clinical_variable
, 188 189 474 475 O
Partial 190 197 476 483 B-clinical_variable
Thromboplastin 198 212 484 498 I-clinical_variable
Time(PTT 213 221 499 507 I-clinical_variable
) 221 222 507 508 I-clinical_variable
< 223 224 509 510 O
/= 224 226 510 512 O
1.5 227 230 513 516 B-upper_bound
X 231 232 517 518 I-upper_bound
ULN 233 236 519 522 I-upper_bound
; 236 237 522 523 O
Total 238 243 524 529 B-clinical_variable
bilirubin 244 253 530 539 I-clinical_variable
< 254 255 540 541 O
/= 255 257 541 543 O
1.5X 258 262 544 548 B-upper_bound
ULN 263 266 549 552 I-upper_bound
; 266 267 552 553 O
Alanine 268 275 554 561 B-clinical_variable
Transaminase 276 288 562 574 I-clinical_variable
( 289 290 575 576 I-clinical_variable
ALT 290 293 576 579 I-clinical_variable
) 293 294 579 580 I-clinical_variable
and 295 298 581 584 I-clinical_variable
Aspartate 299 308 585 594 I-clinical_variable
Aminotransferase 309 325 595 611 I-clinical_variable
( 326 327 612 613 I-clinical_variable
AST 327 330 613 616 I-clinical_variable
) 330 331 616 617 I-clinical_variable
< 332 333 618 619 O
1.5 334 337 620 623 O
X 338 339 624 625 O
ULN 340 343 626 629 O
( 344 345 630 631 O
< 345 346 631 632 O
5 347 348 633 634 O
X 349 350 635 636 O
ULN 351 354 637 640 O
if 355 357 641 643 O
patient 358 365 644 651 O
has 366 369 652 655 O
liver 370 375 656 661 B-cancer
metastasis 376 386 662 672 I-cancer
) 386 387 672 673 O

Chronic 0 7 674 681 B-treatment
treatment 8 17 682 691 I-treatment
with 18 22 692 696 I-treatment
high 23 27 697 701 I-treatment
dose 28 32 702 706 I-treatment
corticosteroids 33 48 707 722 I-treatment
or 49 51 723 725 I-treatment
other 52 57 726 731 I-treatment
immunosuppressive 58 75 732 749 I-treatment
agents 76 82 750 756 I-treatment
. 82 83 756 757 O
Topical 84 91 758 765 B-treatment
, 91 92 765 766 O
inhaled 93 100 767 774 B-treatment
, 100 101 774 775 O
and 102 105 776 779 O
low 106 109 780 783 B-treatment
dose 110 114 784 788 I-treatment
oral 115 119 789 793 I-treatment
corticosteroids 120 135 794 809 I-treatment
are 136 139 810 813 O
allowed 140 147 814 821 O
provided 148 156 822 830 O
stable 157 163 831 837 O
dosing 164 170 838 844 O
for 171 174 845 848 O
at 175 177 849 851 O
least 178 183 852 857 O
2 184 185 858 859 B-lower_bound
weeks 186 191 860 865 I-lower_bound

Fasting 0 7 866 873 B-clinical_variable
serum 8 13 874 879 I-clinical_variable
cholesterol 14 25 880 891 I-clinical_variable
< 26 27 892 893 O
/= 27 29 893 895 O
300 30 33 896 899 B-upper_bound
mg 34 36 900 902 I-upper_bound
/ 36 37 902 903 I-upper_bound
dL 37 39 903 905 I-upper_bound
OR 40 42 906 908 O
< 43 44 909 910 O
/= 44 46 910 912 O
7.75 47 51 913 917 B-upper_bound
mmol 52 56 918 922 I-upper_bound
/ 56 57 922 923 I-upper_bound
L 57 58 923 924 I-upper_bound
AND 59 62 925 928 O
fasting 63 70 929 936 B-clinical_variable
triglycerides 71 84 937 950 I-clinical_variable
< 85 86 951 952 O
/= 86 88 952 954 O
2.5x 89 93 955 959 B-upper_bound
ULN 94 97 960 963 I-upper_bound

Female 0 6 964 970 B-gender
sterilization 7 20 971 984 O
( 21 22 985 986 O
have 22 26 986 990 O
had 27 30 991 994 O
surgical 31 39 995 1003 O
bilateral 40 49 1004 1013 O
oophorectomy 50 62 1014 1026 O
with 63 67 1027 1031 O
or 68 70 1032 1034 O
without 71 78 1035 1042 O
hysterectomy 79 91 1043 1055 B-contraception_consent
) 91 92 1055 1056 O
or 93 95 1057 1059 O
tubal 96 101 1060 1065 B-contraception_consent
ligation 102 110 1066 1074 I-contraception_consent
at 111 113 1075 1077 O
least 114 119 1078 1083 O
six 120 123 1084 1087 B-lower_bound
weeks 124 129 1088 1093 I-lower_bound
before 130 136 1094 1100 I-lower_bound
taking 137 143 1101 1107 O
study 144 149 1108 1113 O
treatment 150 159 1114 1123 B-treatment
. 159 160 1123 1124 O
In 161 163 1125 1127 O
case 164 168 1128 1132 O
of 169 171 1133 1135 O
oophorectomy 172 184 1136 1148 O
alone 185 190 1149 1154 O
, 190 191 1154 1155 O
only 192 196 1156 1160 O
when 197 201 1161 1165 O
the 202 205 1166 1169 O
reproductive 206 218 1170 1182 O
status 219 225 1183 1189 O
of 226 228 1190 1192 O
the 229 232 1193 1196 O
woman 233 238 1197 1202 B-gender
has 239 242 1203 1206 O
been 243 247 1207 1211 O
confirmed 248 257 1212 1221 O
by 258 260 1222 1224 O
follow 261 267 1225 1231 O
up 268 270 1232 1234 O
hormone 271 278 1235 1242 O
level 279 284 1243 1248 O
assessment 285 295 1249 1259 O

For 0 3 1260 1263 O
dose 4 8 1264 1268 O
escalation 9 19 1269 1279 O
cohort 20 26 1280 1286 O
: 26 27 1286 1287 O
Patients 28 36 1288 1296 O
with 37 41 1297 1301 O
histologically 42 56 1302 1316 O
or 57 59 1317 1319 O
cytologically 60 73 1320 1333 O
confirmed 74 83 1334 1343 O
locally 84 91 1344 1351 O
advanced 92 100 1352 1360 O
or 101 103 1361 1363 O
metastatic 104 114 1364 1374 B-cancer
solid 115 120 1375 1380 I-cancer
tumors 121 127 1381 1387 I-cancer
who 128 131 1388 1391 O
have 132 136 1392 1396 O
failed 137 143 1397 1403 O
at 144 146 1404 1406 O
least 147 152 1407 1412 O
one 153 156 1413 1416 B-lower_bound
line 157 161 1417 1421 O
of 162 164 1422 1424 O
therapy 165 172 1425 1432 B-treatment

For 0 3 1433 1436 O
dose 4 8 1437 1441 O
expansion 9 18 1442 1451 O
cohort 19 25 1452 1458 O
: 25 26 1458 1459 O
Patients 27 35 1460 1468 O
with 36 40 1469 1473 O
Stage 41 46 1474 1479 B-lower_bound
IIIB 47 51 1480 1484 I-lower_bound
or 52 54 1485 1487 O
IV 55 57 1488 1490 B-upper_bound
ALK 58 61 1491 1494 B-cancer
+ 62 63 1495 1496 O
NSCLC 64 69 1497 1502 B-cancer
who 70 73 1503 1506 O
have 74 78 1507 1511 O
failed 79 85 1512 1518 O
at 86 88 1519 1521 O
least 89 94 1522 1527 O
one 95 98 1528 1531 O
line 99 103 1532 1536 O
of 104 106 1537 1539 O
therapy 107 114 1540 1547 B-treatment
and 115 118 1548 1551 O
are 119 122 1552 1555 O
progressing 123 134 1556 1567 O
on 135 137 1568 1570 O
an 138 140 1571 1573 O
ALK 141 144 1574 1577 B-treatment
inhibitor 145 154 1578 1587 I-treatment
. 154 155 1587 1588 O
For 156 159 1589 1592 O
dose 160 164 1593 1597 O
expansion 165 174 1598 1607 O
, 174 175 1607 1608 O
patients 176 184 1609 1617 O
who 185 188 1618 1621 O
have 189 193 1622 1626 O
ROS1 194 198 1627 1631 O
rearrangement 199 212 1632 1645 O
testing 213 220 1646 1653 O
by 221 223 1654 1656 O
either 224 230 1657 1663 O
next 231 235 1664 1668 O
generation 236 246 1669 1679 O
sequencing 247 257 1680 1690 O
( 258 259 1691 1692 O
NGS 259 262 1692 1695 O
) 262 263 1695 1696 O
or 264 266 1697 1699 O
fluorescence 267 279 1700 1712 O
in 280 282 1713 1715 O
situ 283 287 1716 1720 O
hybridization 288 301 1721 1734 O
( 302 303 1735 1736 O
FISH 303 307 1736 1740 O
) 307 308 1740 1741 O
will 309 313 1742 1746 O
be 314 316 1747 1749 O
eligible 317 325 1750 1758 O

Highly 0 6 1759 1765 B-contraception_consent
effective 7 16 1766 1775 I-contraception_consent
contraception 17 30 1776 1789 I-contraception_consent
methods 31 38 1790 1797 I-contraception_consent

In 0 2 1798 1800 O
case 3 7 1801 1805 O
of 8 10 1806 1808 O
use 11 14 1809 1812 B-contraception_consent
of 15 17 1813 1815 I-contraception_consent
oral 18 22 1816 1820 I-contraception_consent
contraception 23 36 1821 1834 I-contraception_consent
, 36 37 1834 1835 O
women 38 43 1836 1841 B-gender
should 44 50 1842 1848 O
have 51 55 1849 1853 O
been 56 60 1854 1858 O
stable 61 67 1859 1865 O
on 68 70 1866 1868 O
the 71 74 1869 1872 O
same 75 79 1873 1877 O
pill 80 84 1878 1882 O
for 85 88 1883 1886 O
a 89 90 1887 1888 O
minimum 91 98 1889 1896 O
of 99 101 1897 1899 O
3 102 103 1900 1901 B-lower_bound
months 104 110 1902 1908 I-lower_bound
before 111 117 1909 1915 O
taking 118 124 1916 1922 O
study 125 130 1923 1928 B-treatment
treatment 131 140 1929 1938 I-treatment

In 0 2 1939 1941 O
the 3 6 1942 1945 O
case 7 11 1946 1950 O
of 12 14 1951 1953 O
oophorectomy 15 27 1954 1966 B-treatment
alone 28 33 1967 1972 O
, 33 34 1972 1973 O
only 35 39 1974 1978 O
when 40 44 1979 1983 O
the 45 48 1984 1987 O
reproductive 49 61 1988 2000 O
status 62 68 2001 2007 O
of 69 71 2008 2010 O
the 72 75 2011 2014 O
woman 76 81 2015 2020 B-gender
has 82 85 2021 2024 O
been 86 90 2025 2029 O
confirmed 91 100 2030 2039 O
by 101 103 2040 2042 O
follow 104 110 2043 2049 O
up 111 113 2050 2052 O
hormone 114 121 2053 2060 O
level 122 127 2061 2066 O
assessment 128 138 2067 2077 O
is 139 141 2078 2080 O
she 142 145 2081 2084 O
considered 146 156 2085 2095 O
not 157 160 2096 2099 O
of 161 163 2100 2102 O
child 164 169 2103 2108 O
bearing 170 177 2109 2116 O
potential 178 187 2117 2126 O

Known 0 5 2127 2132 O
history 6 13 2133 2140 O
of 14 16 2141 2143 O
HIV 17 20 2144 2147 B-chronic_disease
seropositivity 21 35 2148 2162 O

Known 0 5 2163 2168 O
impairment 6 16 2169 2179 O
of 17 19 2180 2182 O
gastrointestinal 20 36 2183 2199 O
( 37 38 2200 2201 O
GI 38 40 2201 2203 O
) 40 41 2203 2204 O
function 42 50 2205 2213 O
or 51 53 2214 2216 O
GI 54 56 2217 2219 B-chronic_disease
disease 57 64 2220 2227 I-chronic_disease
that 65 69 2228 2232 O
may 70 73 2233 2236 O
significantly 74 87 2237 2250 O
alter 88 93 2251 2256 O
the 94 97 2257 2260 O
absorption 98 108 2261 2271 O
of 109 111 2272 2274 O
oral 112 116 2275 2279 B-treatment
everolimus 117 127 2280 2290 I-treatment

Known 0 5 2291 2296 O
intolerance 6 17 2297 2308 O
or 18 20 2309 2311 O
hypersensitivity 21 37 2312 2328 O
to 38 40 2329 2331 O
everolimus 41 51 2332 2342 B-allergy_name
or 52 54 2343 2345 O
other 55 60 2346 2351 O
rapamycin 61 70 2352 2361 B-allergy_name
analogs 71 78 2362 2369 O
( 79 80 2370 2371 O
e.g. 80 84 2371 2375 O
sirolimus 85 94 2376 2385 B-allergy_name
, 94 95 2385 2386 O
temsirolimus 96 108 2387 2399 B-allergy_name
) 108 109 2399 2400 O

Male 0 4 2401 2405 B-gender
sterilization 5 18 2406 2419 O
( 19 20 2420 2421 O
at 20 22 2421 2423 O
least 23 28 2424 2429 O
6 29 30 2430 2431 B-lower_bound
months 31 37 2432 2438 I-lower_bound
prior 38 43 2439 2444 I-lower_bound
to 44 46 2445 2447 O
screening)with 47 61 2448 2462 O
the 62 65 2463 2466 O
appropriate 66 77 2467 2478 O
post 78 82 2479 2483 B-treatment
- 82 83 2483 2484 I-treatment
vasectomy 83 92 2484 2493 I-treatment
documentation 93 106 2494 2507 O
of 107 109 2508 2510 O
the 110 113 2511 2514 O
absence 114 121 2515 2522 O
of 122 124 2523 2525 O
sperm 125 130 2526 2531 O
in 131 133 2532 2534 O
the 134 137 2535 2538 O
ejaculate 138 147 2539 2548 O
. 147 148 2548 2549 O
For 149 152 2550 2553 O
female 153 159 2554 2560 B-gender
subjects 160 168 2561 2569 I-gender
on 169 171 2570 2572 O
the 172 175 2573 2576 O
study 176 181 2577 2582 O
the 182 185 2583 2586 O
vasectomized 186 198 2587 2599 O
male 199 203 2600 2604 B-gender
partner 204 211 2605 2612 I-gender
should 212 218 2613 2619 O
be 219 221 2620 2622 O
the 222 225 2623 2626 O
sole 226 230 2627 2631 O
partner 231 238 2632 2639 O
for 239 242 2640 2643 O
that 243 247 2644 2648 O
subject 248 255 2649 2656 O

Measurable 0 10 2657 2667 B-chronic_disease
disease 11 18 2668 2675 I-chronic_disease
by 19 21 2676 2678 O
RECIST 22 28 2679 2685 O
or 29 31 2686 2688 O
evaluable 32 41 2689 2698 O
disease 42 49 2699 2706 O
( 50 51 2707 2708 O
e.g. 51 55 2708 2712 O
, 55 56 2712 2713 O
bone 57 61 2714 2718 B-cancer
metastasis 62 72 2719 2729 I-cancer
, 72 73 2729 2730 O
or 74 76 2731 2733 O
lesions 77 84 2734 2741 O
which 85 90 2742 2747 O
do 91 93 2748 2750 O
not 94 97 2751 2754 O
fulfill 98 105 2755 2762 O
RECIST 106 112 2763 2769 O
criteria 113 121 2770 2778 O
for 122 125 2779 2782 O
metastatic 126 136 2783 2793 B-cancer
disease 137 144 2794 2801 I-cancer
) 144 145 2801 2802 O

Medication 0 10 2803 2813 B-treatment
with 11 15 2814 2818 O
a 16 17 2819 2820 O
known 18 23 2821 2826 O
risk 24 28 2827 2831 O
of 29 31 2832 2834 O
prolonging 32 42 2835 2845 O
the 43 46 2846 2849 O
QT 47 49 2850 2852 B-clinical_variable
interval 50 58 2853 2861 I-clinical_variable
or 59 61 2862 2864 O
inducing 62 70 2865 2873 O
Torsades 71 79 2874 2882 B-chronic_disease
de 80 82 2883 2885 I-chronic_disease
Pointes 83 90 2886 2893 I-chronic_disease

Medications 0 11 2894 2905 B-treatment
with 12 16 2906 2910 I-treatment
a 17 18 2911 2912 I-treatment
low 19 22 2913 2916 I-treatment
therapeutic 23 34 2917 2928 I-treatment
index 35 40 2929 2934 I-treatment
that 41 45 2935 2939 O
are 46 49 2940 2943 O
primarily 50 59 2944 2953 O
metabolized 60 71 2954 2965 O
by 72 74 2966 2968 O
CYP3A4/5 75 83 2969 2977 O
, 83 84 2977 2978 O
CYP2C8 85 91 2979 2985 O
and/or 92 98 2986 2992 O
CYP2C9 99 105 2993 2999 O

Negative 0 8 3000 3008 O
serum 9 14 3009 3014 O
or 15 17 3015 3017 O
urine 18 23 3018 3023 O
pregnancy 24 33 3024 3033 B-pregnancy
test 34 38 3034 3038 O
beta 39 43 3039 3043 B-clinical_variable
- 43 44 3043 3044 I-clinical_variable
Human 44 49 3044 3049 I-clinical_variable
Chorionic 50 59 3050 3059 I-clinical_variable
Gonadotropin 60 72 3060 3072 I-clinical_variable
( 73 74 3073 3074 I-clinical_variable
beta 74 78 3074 3078 I-clinical_variable
hCG 79 82 3079 3082 I-clinical_variable
) 82 83 3082 3083 I-clinical_variable
within 84 90 3084 3090 O
2 91 92 3091 3092 B-upper_bound
weeks 93 98 3093 3098 I-upper_bound
prior 99 104 3099 3104 I-upper_bound
to 105 107 3105 3107 O
receiving 108 117 3108 3117 O
the 118 121 3118 3121 O
first 122 127 3122 3127 O
dose 128 132 3128 3132 O
of 133 135 3133 3135 O
study 136 141 3136 3141 O
medication 142 152 3142 3152 B-treatment
for 153 156 3153 3156 O
women 157 162 3157 3162 B-gender
of 163 165 3163 3165 O
childbearing 166 178 3166 3178 O
age 179 182 3179 3182 B-age

Non 0 3 3183 3186 B-cancer
- 3 4 3186 3187 I-cancer
ALK 4 7 3187 3190 I-cancer
- 7 8 3190 3191 I-cancer
positive 8 16 3191 3199 I-cancer
NSCLC 17 22 3200 3205 I-cancer
patients 23 31 3206 3214 O
with 32 36 3215 3219 O
CNS 37 40 3220 3223 B-cancer
metastasis 41 51 3224 3234 I-cancer
should 52 58 3235 3241 O
have 59 63 3242 3246 O
completed 64 73 3247 3256 O
a 74 75 3257 3258 O
course 76 82 3259 3265 O
of 83 85 3266 3268 O
therapy 86 93 3269 3276 B-treatment
would 94 99 3277 3282 O
be 100 102 3283 3285 O
eligible 103 111 3286 3294 O
for 112 115 3295 3298 O
the 116 119 3299 3302 O
study 120 125 3303 3308 O
provided 126 134 3309 3317 O
they 135 139 3318 3322 O
are 140 143 3323 3326 O
clinically 144 154 3327 3337 O
stable 155 161 3338 3344 O
for 162 165 3345 3348 O
1 166 167 3349 3350 B-upper_bound
month 168 173 3351 3356 I-upper_bound

Patient 0 7 3357 3364 O
has 8 11 3365 3368 O
clinically 12 22 3369 3379 O
significant 23 34 3380 3391 O
, 34 35 3391 3392 O
uncontrolled 36 48 3393 3405 O
heart 49 54 3406 3411 B-chronic_disease
disease 55 62 3412 3419 I-chronic_disease
and/or 63 69 3420 3426 O
recent 70 76 3427 3433 O
cardiac 77 84 3434 3441 B-chronic_disease
event 85 90 3442 3447 I-chronic_disease
( 91 92 3448 3449 O
within 92 98 3449 3455 O
6 99 100 3456 3457 B-upper_bound
months 101 107 3458 3464 I-upper_bound
) 107 108 3464 3465 O

Patient 0 7 3466 3473 O
must 8 12 3474 3478 O
have 13 17 3479 3483 O
completed 18 27 3484 3493 O
any 28 31 3494 3497 O
systemic 32 40 3498 3506 B-treatment
therapy 41 48 3507 3514 I-treatment
regimens 49 57 3515 3523 I-treatment
( 58 59 3524 3525 O
except 59 65 3525 3531 O
an 66 68 3532 3534 O
ALK 69 72 3535 3538 B-treatment
inhibitor 73 82 3539 3548 I-treatment
) 82 83 3548 3549 O
and 84 87 3550 3553 O
therapeutic 88 99 3554 3565 B-treatment
radiation 100 109 3566 3575 I-treatment
a 110 111 3576 3577 O
minimum 112 119 3578 3585 O
of 120 122 3586 3588 O
21 123 125 3589 3591 B-lower_bound
days 126 130 3592 3596 I-lower_bound
prior 131 136 3597 3602 I-lower_bound
to 137 139 3603 3605 O
initiation 140 150 3606 3616 O
of 151 153 3617 3619 O
study 154 159 3620 3625 B-treatment
therapy 160 167 3626 3633 I-treatment

Patient 0 7 3634 3641 O
must 8 12 3642 3646 O
have 13 17 3647 3651 O
performance 18 29 3652 3663 B-clinical_variable
status 30 36 3664 3670 I-clinical_variable
< 37 38 3671 3672 O
/=2 38 41 3672 3675 O
on 42 44 3676 3678 O
the 45 48 3679 3682 O
ECOG 49 53 3683 3687 B-clinical_variable
Performance 54 65 3688 3699 I-clinical_variable
Scale 66 71 3700 3705 I-clinical_variable

Patient 0 7 3706 3713 O
should 8 14 3714 3720 O
also 15 19 3721 3725 O
avoid 20 25 3726 3731 O
close 26 31 3732 3737 O
contact 32 39 3738 3745 O
with 40 44 3746 3750 O
others 45 51 3751 3757 O
who 52 55 3758 3761 O
have 56 60 3762 3766 O
received 61 69 3767 3775 O
live 70 74 3776 3780 B-treatment
attenuated 75 85 3781 3791 I-treatment
vaccines 86 94 3792 3800 I-treatment
. 94 95 3800 3801 O
Examples 96 104 3802 3810 O
of 105 107 3811 3813 O
live 108 112 3814 3818 O
attenuated 113 123 3819 3829 O
vaccines 124 132 3830 3838 O
include 133 140 3839 3846 O
intranasal 141 151 3847 3857 B-treatment
influenza 152 161 3858 3867 I-treatment
, 161 162 3867 3868 O
measles 163 170 3869 3876 B-treatment
, 170 171 3876 3877 O
mumps 172 177 3878 3883 B-treatment
, 177 178 3883 3884 O
rubella 179 186 3885 3892 B-treatment
, 186 187 3892 3893 O
oral 188 192 3894 3898 B-treatment
polio 193 198 3899 3904 I-treatment
, 198 199 3904 3905 O
Bacillus 200 208 3906 3914 B-treatment
Calmette 209 217 3915 3923 I-treatment
- 217 218 3923 3924 I-treatment
Guérin 218 224 3924 3930 I-treatment
( 225 226 3931 3932 I-treatment
BCG 226 229 3932 3935 I-treatment
) 229 230 3935 3936 I-treatment
, 230 231 3936 3937 O
yellow 232 238 3938 3944 B-treatment
fever 239 244 3945 3950 I-treatment
, 244 245 3950 3951 O
varicella 246 255 3952 3961 B-treatment
and 256 259 3962 3965 O
TY21a 260 265 3966 3971 B-treatment
typhoid 266 273 3972 3979 I-treatment
vaccines 274 282 3980 3988 I-treatment

Patient 0 7 3989 3996 O
will 8 12 3997 4001 O
have 13 17 4002 4006 O
a 18 19 4007 4008 O
tumor 20 25 4009 4014 B-cancer
suitable 26 34 4015 4023 O
for 35 38 4024 4027 O
fine 39 43 4028 4032 O
needle 44 50 4033 4039 B-treatment
aspirates 51 60 4040 4049 I-treatment
( 61 62 4050 4051 I-treatment
FNA 62 65 4051 4054 I-treatment
) 65 66 4054 4055 I-treatment
or 67 69 4056 4058 O
core 70 74 4059 4063 B-treatment
biopsy 75 81 4064 4070 I-treatment
for 82 85 4071 4074 O
research 86 94 4075 4083 O
purposes 95 103 4084 4092 O
( 104 105 4093 4094 O
2 105 106 4094 4095 B-lower_bound
or 107 109 4096 4098 O
more 110 114 4099 4103 O
FNAs 115 119 4104 4108 B-treatment
if 120 122 4109 4111 O
core 123 127 4112 4116 O
is 128 130 4117 4119 O
not 131 134 4120 4123 O
feasible 135 143 4124 4132 O
) 143 144 4132 4133 O

Patients 0 8 4134 4142 O
currently 9 18 4143 4152 O
receiving 19 28 4153 4162 O
anticancer 29 39 4163 4173 B-treatment
therapies 40 49 4174 4183 I-treatment
or 50 52 4184 4186 O
who 53 56 4187 4190 O
have 57 61 4191 4195 O
received 62 70 4196 4204 O
anticancer 71 81 4205 4215 O
therapies 82 91 4216 4225 O
within 92 98 4226 4232 O
4 99 100 4233 4234 B-upper_bound
weeks 101 106 4235 4240 I-upper_bound
including 107 116 4241 4250 O
chemotherapy 117 129 4251 4263 B-treatment
, 129 130 4263 4264 O
radiation 131 140 4265 4274 B-treatment
therapy 141 148 4275 4282 I-treatment
, 148 149 4282 4283 O
antibody 150 158 4284 4292 B-treatment
based 159 164 4293 4298 I-treatment
therapy 165 172 4299 4306 I-treatment
, 172 173 4306 4307 O
etc 174 177 4308 4311 O

Patients 0 8 4312 4320 O
who 9 12 4321 4324 O
are 13 16 4325 4328 O
currently 17 26 4329 4338 O
part 27 31 4339 4343 O
of 32 34 4344 4346 O
or 35 37 4347 4349 O
have 38 42 4350 4354 O
participated 43 55 4355 4367 O
in 56 58 4368 4370 O
any 59 62 4371 4374 O
clinical 63 71 4375 4383 O
investigation 72 85 4384 4397 O
with 86 90 4398 4402 O
an 91 93 4403 4405 O
investigational 94 109 4406 4421 B-treatment
drug 110 114 4422 4426 I-treatment
within 115 121 4427 4433 O
1 122 123 4434 4435 B-upper_bound
month 124 129 4436 4441 I-upper_bound
prior 130 135 4442 4447 B-treatment
to 136 138 4448 4450 I-treatment
dosing 139 145 4451 4457 I-treatment
( 146 147 4458 4459 O
except 147 153 4459 4465 O
ALK 154 157 4466 4469 B-treatment
inhibitors 158 168 4470 4480 I-treatment
) 168 169 4480 4481 O

Patients 0 8 4482 4490 O
who 9 12 4491 4494 O
have 13 17 4495 4499 O
a 18 19 4500 4501 O
history 20 27 4502 4509 O
of 28 30 4510 4512 O
another 31 38 4513 4520 O
primary 39 46 4521 4528 O
malignancy 47 57 4529 4539 B-cancer
unless 58 64 4540 4546 O
the 65 68 4547 4550 O
patient 69 76 4551 4558 O
has 77 80 4559 4562 O
been 81 85 4563 4567 O
disease 86 93 4568 4575 O
free 94 98 4576 4580 O
for 99 102 4581 4584 O
> 103 104 4585 4586 O
/= 104 106 4586 4588 O
3 107 108 4589 4590 B-lower_bound
years 109 114 4591 4596 I-lower_bound

Patients 0 8 4597 4605 O
who 9 12 4606 4609 O
have 13 17 4610 4614 O
any 18 21 4615 4618 O
severe 22 28 4619 4625 O
and/or 29 35 4626 4632 O
uncontrolled 36 48 4633 4645 O
medical 49 56 4646 4653 B-chronic_disease
conditions 57 67 4654 4664 I-chronic_disease

Patients 0 8 4665 4673 O
who 9 12 4674 4677 O
have 13 17 4678 4682 O
received 18 26 4683 4691 O
live 27 31 4692 4696 B-treatment
attenuated 32 42 4697 4707 I-treatment
vaccines 43 51 4708 4716 I-treatment
within 52 58 4717 4723 O
1 59 60 4724 4725 B-upper_bound
week 61 65 4726 4730 I-upper_bound
of 66 68 4731 4733 O
start 69 74 4734 4739 O
of 75 77 4740 4742 O
everolimus 78 88 4743 4753 B-treatment
and 89 92 4754 4757 O
during 93 99 4758 4764 O
the 100 103 4765 4768 O
study 104 109 4769 4774 O

Patients 0 8 4775 4783 O
who 9 12 4784 4787 O
have 13 17 4788 4792 O
received 18 26 4793 4801 O
prior 27 32 4802 4807 O
everolimus 33 43 4808 4818 B-treatment
or 44 46 4819 4821 O
ceritinib 47 56 4822 4831 B-treatment

Patients 0 8 4832 4840 O
with 9 13 4841 4845 O
a 14 15 4846 4847 O
history 16 23 4848 4855 O
of 24 26 4856 4858 O
non 27 30 4859 4862 O
- 30 31 4862 4863 O
compliance 31 41 4863 4873 O
to 42 44 4874 4876 O
medical 45 52 4877 4884 B-treatment
regimens 53 61 4885 4893 I-treatment
or 62 64 4894 4896 O
who 65 68 4897 4900 O
are 69 72 4901 4904 O
considered 73 83 4905 4915 O
potentially 84 95 4916 4927 O
unreliable 96 106 4928 4938 O
or 107 109 4939 4941 O
will 110 114 4942 4946 O
not 115 118 4947 4950 O
be 119 121 4951 4953 O
able 122 126 4954 4958 O
to 127 129 4959 4961 O
complete 130 138 4962 4970 O
the 139 142 4971 4974 O
entire 143 149 4975 4981 O
study 150 155 4982 4987 O

Patients 0 8 4988 4996 O
with 9 13 4997 5001 O
known 14 19 5002 5007 O
history 20 27 5008 5015 O
of 28 30 5016 5018 O
extensive 31 40 5019 5028 O
disseminated 41 53 5029 5041 O
bilateral 54 63 5042 5051 O
interstitial 64 76 5052 5064 B-chronic_disease
fibrosis 77 85 5065 5073 I-chronic_disease
or 86 88 5074 5076 O
interstitial 89 101 5077 5089 B-chronic_disease
lung 102 106 5090 5094 I-chronic_disease
disease 107 114 5095 5102 I-chronic_disease
, 114 115 5102 5103 O
including 116 125 5104 5113 O
a 126 127 5114 5115 O
history 128 135 5116 5123 O
of 136 138 5124 5126 O
pneumonitis 139 150 5127 5138 B-chronic_disease
, 150 151 5138 5139 O
hypersensitivity 152 168 5140 5156 B-chronic_disease
pneumonitis 169 180 5157 5168 I-chronic_disease
, 180 181 5168 5169 O
interstitial 182 194 5170 5182 B-chronic_disease
pneumonia 195 204 5183 5192 I-chronic_disease
, 204 205 5192 5193 O
obliterative 206 218 5194 5206 B-chronic_disease
bronchiolitis 219 232 5207 5220 I-chronic_disease
, 232 233 5220 5221 O
and 234 237 5222 5225 O
clinically 238 248 5226 5236 O
significant 249 260 5237 5248 O
radiation 261 270 5249 5258 B-chronic_disease
pneumonitis 271 282 5259 5270 I-chronic_disease
( 283 284 5271 5272 O
i.e. 284 288 5272 5276 O
affecting 289 298 5277 5286 O
activities 299 309 5287 5297 O
of 310 312 5298 5300 O
daily 313 318 5301 5306 O
living 319 325 5307 5313 O
or 326 328 5314 5316 O
requiring 329 338 5317 5326 O
therapeutic 339 350 5327 5338 B-treatment
intervention 351 363 5339 5351 I-treatment
) 363 364 5351 5352 O

Patients 0 8 5353 5361 O
with 9 13 5362 5366 O
known 14 19 5367 5372 O
hypersensitivity 20 36 5373 5389 O
to 37 39 5390 5392 O
any 40 43 5393 5396 O
of 44 46 5397 5399 O
the 47 50 5400 5403 O
excipients 51 61 5404 5414 O
of 62 64 5415 5417 O
ceritinib 65 74 5418 5427 B-treatment
( 75 76 5428 5429 O
microcrystalline 76 92 5429 5445 B-treatment
cellulose 93 102 5446 5455 I-treatment
, 102 103 5455 5456 O
mannitol 104 112 5457 5465 B-treatment
, 112 113 5465 5466 O
crospovidone 114 126 5467 5479 B-treatment
, 126 127 5479 5480 O
colloidal 128 137 5481 5490 B-treatment
silicon 138 145 5491 5498 I-treatment
dioxide 146 153 5499 5506 I-treatment
and 154 157 5507 5510 O
magnesium 158 167 5511 5520 B-treatment
stearate 168 176 5521 5529 I-treatment
) 176 177 5529 5530 O

Placement 0 9 5531 5540 O
of 10 12 5541 5543 O
an 13 15 5544 5546 O
intrauterine 16 28 5547 5559 B-treatment
device 29 35 5560 5566 I-treatment
( 36 37 5567 5568 I-treatment
IUD 37 40 5568 5571 I-treatment
) 40 41 5571 5572 I-treatment
or 42 44 5573 5575 O
intrauterine 45 57 5576 5588 B-treatment
system 58 64 5589 5595 I-treatment
( 65 66 5596 5597 I-treatment
IUS 66 69 5597 5600 I-treatment
) 69 70 5600 5601 I-treatment

Pregnant 0 8 5602 5610 B-pregnancy

Receiving 0 9 5611 5620 O
medications 10 21 5621 5632 O
that 22 26 5633 5637 O
meet 27 31 5638 5642 O
one 32 35 5643 5646 O
of 36 38 5647 5649 O
the 39 42 5650 5653 O
following 43 52 5654 5663 O
criteria 53 61 5664 5672 O
and 62 65 5673 5676 O
that 66 70 5677 5681 O
can 71 74 5682 5685 O
not 74 77 5685 5688 O
be 78 80 5689 5691 O
discontinued 81 93 5692 5704 O
at 94 96 5705 5707 O
least 97 102 5708 5713 O
1 103 104 5714 5715 B-lower_bound
week 105 109 5716 5720 I-lower_bound
prior 110 115 5721 5726 I-lower_bound
to 116 118 5727 5729 O
the 119 122 5730 5733 O
start 123 128 5734 5739 O
of 129 131 5740 5742 O
treatment 132 141 5743 5752 B-treatment
with 142 146 5753 5757 O
ceritinib 147 156 5758 5767 B-treatment
and 157 160 5768 5771 O
for 161 164 5772 5775 O
the 165 168 5776 5779 O
duration 169 177 5780 5788 O
of 178 180 5789 5791 O
the 181 184 5792 5795 O
study 185 190 5796 5801 O
participation 191 204 5802 5815 O

Sexually 0 8 5816 5824 O
active 9 15 5825 5831 O
males 16 21 5832 5837 B-gender
unless 22 28 5838 5844 O
they 29 33 5845 5849 O
use 34 37 5850 5853 B-contraception_consent
a 38 39 5854 5855 I-contraception_consent
condom 40 46 5856 5862 I-contraception_consent
during 47 53 5863 5869 I-contraception_consent
intercourse 54 65 5870 5881 I-contraception_consent
while 66 71 5882 5887 O
taking 72 78 5888 5894 O
drug 79 83 5895 5899 O
and 84 87 5900 5903 O
for 88 91 5904 5907 O
3 92 93 5908 5909 B-lower_bound
months 94 100 5910 5916 I-lower_bound
after 101 106 5917 5922 I-lower_bound
the 107 110 5923 5926 O
last 111 115 5927 5931 O
dose 116 120 5932 5936 O
of 121 123 5937 5939 O
study 124 129 5940 5945 O
treatment 130 139 5946 5955 B-treatment
. 139 140 5955 5956 O
Male 141 145 5957 5961 B-gender
patients 146 154 5962 5970 I-gender
for 155 158 5971 5974 O
3 159 160 5975 5976 O
months 161 167 5977 5983 O
should 168 174 5984 5990 O
not 175 178 5991 5994 O
father 179 185 5995 6001 O
a 186 187 6002 6003 O
child 188 193 6004 6009 O
in 194 196 6010 6012 O
this 197 201 6013 6017 O
period 202 208 6018 6024 O
. 208 209 6024 6025 O
A 210 211 6026 6027 O
condom 212 218 6028 6034 O
is 219 221 6035 6037 O
required 222 230 6038 6046 O
to 231 233 6047 6049 O
be 234 236 6050 6052 O
used 237 241 6053 6057 O
also 242 246 6058 6062 O
by 247 249 6063 6065 O
vasectomized 250 262 6066 6078 O
men 263 266 6079 6082 O
in 267 269 6083 6085 O
order 270 275 6086 6091 O
to 276 278 6092 6094 O
prevent 279 286 6095 6102 O
delivery 287 295 6103 6111 O
of 296 298 6112 6114 O
the 299 302 6115 6118 O
drug 303 307 6119 6123 O
via 308 311 6124 6127 O
seminal 312 319 6128 6135 O
fluid 320 325 6136 6141 O
. 325 326 6141 6142 O
Also 327 331 6143 6147 O
male 332 336 6148 6152 B-gender
patients 337 345 6153 6161 I-gender
whose 346 351 6162 6167 O
sexual 352 358 6168 6174 O
partner(s 359 368 6175 6184 O
) 368 369 6184 6185 O
are 370 373 6186 6189 O
WOCBP 374 379 6190 6195 O
who 380 383 6196 6199 O
are 384 387 6200 6203 B-contraception_consent
not 388 391 6204 6207 I-contraception_consent
willing 392 399 6208 6215 I-contraception_consent
to 400 402 6216 6218 I-contraception_consent
use 403 406 6219 6222 I-contraception_consent
adequate 407 415 6223 6231 I-contraception_consent
contraception 416 429 6232 6245 I-contraception_consent
during 430 436 6246 6252 O
the 437 440 6253 6256 O
study 441 446 6257 6262 O
and 447 450 6263 6266 O
for 451 454 6267 6270 O
3 455 456 6271 6272 O
months 457 463 6273 6279 O
after 464 469 6280 6285 O
the 470 473 6286 6289 O
end 474 477 6290 6293 O
of 478 480 6294 6296 O
enrollment 481 491 6297 6307 O

Strong 0 6 6308 6314 B-treatment
inhibitors 7 17 6315 6325 I-treatment
or 18 20 6326 6328 I-treatment
strong 21 27 6329 6335 I-treatment
inducers 28 36 6336 6344 I-treatment
of 37 39 6345 6347 I-treatment
CYP3A4/5 40 48 6348 6356 I-treatment

Therapeutic 0 11 6357 6368 O
doses 12 17 6369 6374 O
of 18 20 6375 6377 O
warfarin 21 29 6378 6386 B-treatment
sodium 30 36 6387 6393 I-treatment
( 37 38 6394 6395 I-treatment
Coumadin 38 46 6395 6403 I-treatment
) 46 47 6403 6404 I-treatment
or 48 50 6405 6407 O
any 51 54 6408 6411 O
other 55 60 6412 6417 O
coumadin 61 69 6418 6426 O
- 69 70 6426 6427 O
derived 70 77 6427 6434 O
anti 78 82 6435 6439 B-treatment
- 82 83 6439 6440 I-treatment
coagulant 83 92 6440 6449 I-treatment
. 92 93 6449 6450 O
Anticoagulants 94 108 6451 6465 B-treatment
not 109 112 6466 6469 O
derived 113 120 6470 6477 O
from 121 125 6478 6482 O
warfarin 126 134 6483 6491 O
are 135 138 6492 6495 O
allowed 139 146 6496 6503 O
( 147 148 6504 6505 O
eg 148 150 6505 6507 O
, 150 151 6507 6508 O
dabigatran 152 162 6509 6519 B-treatment
, 162 163 6519 6520 O
rivaroxaban 164 175 6521 6532 B-treatment
, 175 176 6532 6533 O
apixaban 177 185 6534 6542 B-treatment
) 185 186 6542 6543 O

Uncontrolled 0 12 6544 6556 O
diabetes 13 21 6557 6565 B-chronic_disease
mellitus 22 30 6566 6574 I-chronic_disease
as 31 33 6575 6577 O
defined 34 41 6578 6585 O
by 42 44 6586 6588 O
hemoglobin 45 55 6589 6599 B-clinical_variable
A1c 56 59 6600 6603 I-clinical_variable
( 60 61 6604 6605 I-clinical_variable
HbA1c 61 66 6605 6610 I-clinical_variable
) 66 67 6610 6611 I-clinical_variable
> 68 69 6612 6613 O
8 69 70 6613 6614 B-lower_bound
% 70 71 6614 6615 I-lower_bound
despite 72 79 6616 6623 O
adequate 80 88 6624 6632 O
therapy 89 96 6633 6640 B-treatment
. 96 97 6640 6641 O
Patients 98 106 6642 6650 O
with 107 111 6651 6655 O
a 112 113 6656 6657 O
known 114 119 6658 6663 O
history 120 127 6664 6671 O
of 128 130 6672 6674 O
impaired 131 139 6675 6683 B-chronic_disease
fasting 140 147 6684 6691 I-chronic_disease
glucose 148 155 6692 6699 I-chronic_disease
or 156 158 6700 6702 O
diabetes 159 167 6703 6711 B-chronic_disease
mellitus 168 176 6712 6720 I-chronic_disease
( 177 178 6721 6722 I-chronic_disease
DM 178 180 6722 6724 I-chronic_disease
) 180 181 6724 6725 I-chronic_disease
may 182 185 6726 6729 O
be 186 188 6730 6732 O
included 189 197 6733 6741 O
, 197 198 6741 6742 O
however 199 206 6743 6750 O
blood 207 212 6751 6756 O
glucose 213 220 6757 6764 O
and 221 224 6765 6768 O
antidiabetic 225 237 6769 6781 B-treatment
treatment 238 247 6782 6791 I-treatment
must 248 252 6792 6796 O
be 253 255 6797 6799 O
monitored 256 265 6800 6809 O
closely 266 273 6810 6817 O
throughout 274 284 6818 6828 O
the 285 288 6829 6832 O
trial 289 294 6833 6838 O
and 295 298 6839 6842 O
adjusted 299 307 6843 6851 O
as 308 310 6852 6854 O
necessary 311 320 6855 6864 O

Unstable 0 8 6865 6873 O
or 9 11 6874 6876 O
increasing 12 22 6877 6887 O
doses 23 28 6888 6893 O
of 29 31 6894 6896 O
corticosteroids 32 47 6897 6912 B-treatment

Use 0 3 6913 6916 B-contraception_consent
of 4 6 6917 6919 I-contraception_consent
oral 7 11 6920 6924 I-contraception_consent
, 11 12 6924 6925 I-contraception_consent
injected 13 21 6926 6934 I-contraception_consent
or 22 24 6935 6937 I-contraception_consent
implanted 25 34 6938 6947 I-contraception_consent
hormonal 35 43 6948 6956 I-contraception_consent
methods 44 51 6957 6964 I-contraception_consent
of 52 54 6965 6967 I-contraception_consent
contraception 55 68 6968 6981 I-contraception_consent
or 69 71 6982 6984 I-contraception_consent
other 72 77 6985 6990 I-contraception_consent
forms 78 83 6991 6996 I-contraception_consent
of 84 86 6997 6999 I-contraception_consent
hormonal 87 95 7000 7008 I-contraception_consent
contraception 96 109 7009 7022 I-contraception_consent
that 110 114 7023 7027 O
have 115 119 7028 7032 O
comparable 120 130 7033 7043 O
efficacy 131 139 7044 7052 O
( 140 141 7053 7054 O
failure 141 148 7054 7061 B-clinical_variable
rate 149 153 7062 7066 I-clinical_variable
< 154 155 7067 7068 O
1 156 157 7069 7070 B-upper_bound
% 157 158 7070 7071 I-upper_bound
) 158 159 7071 7072 O

Women 0 5 7073 7078 B-gender
are 6 9 7079 7082 O
considered 10 20 7083 7093 O
post 21 25 7094 7098 O
- 25 26 7098 7099 O
menopausal 26 36 7099 7109 O
and 37 40 7110 7113 O
not 41 44 7114 7117 O
of 45 47 7118 7120 O
child 48 53 7121 7126 O
bearing 54 61 7127 7134 O
potential 62 71 7135 7144 O
if 72 74 7145 7147 O
they 75 79 7148 7152 O
have 80 84 7153 7157 O
had 85 88 7158 7161 O
12 89 91 7162 7164 B-upper_bound
months 92 98 7165 7171 I-upper_bound
of 99 101 7172 7174 O
natural 102 109 7175 7182 O
( 110 111 7183 7184 O
spontaneous 111 122 7184 7195 O
) 122 123 7195 7196 O
amenorrhea 124 134 7197 7207 B-chronic_disease
with 135 139 7208 7212 O
an 140 142 7213 7215 O
appropriate 143 154 7216 7227 O
clinical 155 163 7228 7236 O
profile 164 171 7237 7244 O
( 172 173 7245 7246 O
e.g. 173 177 7246 7250 O
, 177 178 7250 7251 O
age 179 182 7252 7255 B-age
appropriate 183 194 7256 7267 O
, 194 195 7267 7268 O
history 196 203 7269 7276 O
of 204 206 7277 7279 O
vasomotor 207 216 7280 7289 O
symptoms 217 225 7290 7298 O
) 225 226 7298 7299 O
or 227 229 7300 7302 O
have 230 234 7303 7307 O
had 235 238 7308 7311 O
surgical 239 247 7312 7320 B-treatment
bilateral 248 257 7321 7330 I-treatment
oophorectomy 258 270 7331 7343 I-treatment
( 271 272 7344 7345 O
with 272 276 7345 7349 O
or 277 279 7350 7352 O
without 280 287 7353 7360 O
hysterectomy 288 300 7361 7373 B-treatment
) 300 301 7373 7374 O
or 302 304 7375 7377 O
tubal 305 310 7378 7383 B-treatment
ligation 311 319 7384 7392 I-treatment
at 320 322 7393 7395 O
least 323 328 7396 7401 O
six 329 332 7402 7405 B-upper_bound
weeks 333 338 7406 7411 I-upper_bound
prior 339 344 7412 7417 I-upper_bound
to 345 347 7418 7420 O
screening 348 357 7421 7430 O

Women 0 5 7431 7436 B-gender
of 6 8 7437 7439 O
child 9 14 7440 7445 O
- 14 15 7445 7446 O
bearing 15 22 7446 7453 O
potential 23 32 7454 7463 O
( 33 34 7464 7465 O
WOCBP 34 39 7465 7470 O
) 39 40 7470 7471 O
, 40 41 7471 7472 O
defined 42 49 7473 7480 O
as 50 52 7481 7483 O
all 53 56 7484 7487 O
women 57 62 7488 7493 B-gender
physiologically 63 78 7494 7509 O
capable 79 86 7510 7517 O
of 87 89 7518 7520 O
becoming 90 98 7521 7529 O
pregnant 99 107 7530 7538 B-pregnancy
, 107 108 7538 7539 O
unless 109 115 7540 7546 O
they 116 120 7547 7551 O
are 121 124 7552 7555 O
using 125 130 7556 7561 B-contraception_consent
highly 131 137 7562 7568 I-contraception_consent
effective 138 147 7569 7578 I-contraception_consent
methods 148 155 7579 7586 I-contraception_consent
of 156 158 7587 7589 I-contraception_consent
contraception 159 172 7590 7603 I-contraception_consent
during 173 179 7604 7610 O
dosing 180 186 7611 7617 O
and 187 190 7618 7621 O
for 191 194 7622 7625 O
3 195 196 7626 7627 B-upper_bound
months 197 203 7628 7634 I-upper_bound
after 204 209 7635 7640 I-upper_bound
the 210 213 7641 7644 O
last 214 218 7645 7649 O
dose 219 223 7650 7654 O
of 224 226 7655 7657 O
study 227 232 7658 7663 B-treatment
treatment 233 242 7664 7673 I-treatment

active 0 6 7674 7680 O
( 7 8 7681 7682 O
acute 8 13 7682 7687 O
or 14 16 7688 7690 O
chronic 17 24 7691 7698 O
) 24 25 7698 7699 O
or 26 28 7700 7702 O
uncontrolled 29 41 7703 7715 B-chronic_disease
severe 42 48 7716 7722 I-chronic_disease
infection 49 58 7723 7732 I-chronic_disease
, 58 59 7732 7733 O
liver 60 65 7734 7739 B-chronic_disease
disease 66 73 7740 7747 I-chronic_disease
such 74 78 7748 7752 O
as 79 81 7753 7755 O
cirrhosis 82 91 7756 7765 B-chronic_disease
, 91 92 7765 7766 O
decompensated 93 106 7767 7780 B-chronic_disease
liver 107 112 7781 7786 I-chronic_disease
disease 113 120 7787 7794 I-chronic_disease
, 120 121 7794 7795 O
and 122 125 7796 7799 O
chronic 126 133 7800 7807 B-chronic_disease
hepatitis 134 143 7808 7817 I-chronic_disease
( 144 145 7818 7819 O
i.e. 145 149 7819 7823 O
quantifiable 150 162 7824 7836 O
hepatitis 163 172 7837 7846 B-chronic_disease
B 173 174 7847 7848 I-chronic_disease
virus 175 180 7849 7854 I-chronic_disease
test 181 185 7855 7859 O
[ 186 187 7860 7861 O
HBV 187 190 7861 7864 O
- 190 191 7864 7865 O
DNA 191 194 7865 7868 O
] 194 195 7868 7869 O
and/or 196 202 7870 7876 O
positive 203 211 7877 7885 O
hepatitis 212 221 7886 7895 O
B 222 223 7896 7897 O
surface 224 231 7898 7905 O
antigen 232 239 7906 7913 O
[ 240 241 7914 7915 O
HbsAg 241 246 7915 7920 O
] 246 247 7920 7921 O
, 247 248 7921 7922 O
quantifiable 249 261 7923 7935 O
hepatitis 262 271 7936 7945 B-chronic_disease
C 272 273 7946 7947 I-chronic_disease
virus 274 279 7948 7953 I-chronic_disease
test 280 284 7954 7958 O
[ 285 286 7959 7960 O
HCV 286 289 7960 7963 O
- 289 290 7963 7964 O
RNA 290 293 7964 7967 O
] 293 294 7967 7968 O
) 294 295 7968 7969 O

active 0 6 7970 7976 O
, 6 7 7976 7977 O
bleeding 8 16 7978 7986 B-chronic_disease
diathesis 17 26 7987 7996 I-chronic_disease

corrected 0 9 7997 8006 O
QTc 10 13 8007 8010 B-clinical_variable
> 14 15 8011 8012 O
450 16 19 8013 8016 B-lower_bound
msec 20 24 8017 8021 I-lower_bound
using 25 30 8022 8027 O
Fridericia 31 41 8028 8038 O
correction 42 52 8039 8049 O
on 53 55 8050 8052 O
the 56 59 8053 8056 O
screening 60 69 8057 8066 O
electrocardiogram 70 87 8067 8084 O
( 88 89 8085 8086 O
ECG 89 92 8086 8089 O
) 92 93 8089 8090 O

enzyme 0 6 8091 8097 B-treatment
- 6 7 8097 8098 I-treatment
inducing 7 15 8098 8106 I-treatment
anticonvulsive 16 30 8107 8121 I-treatment
agents 31 37 8122 8128 I-treatment

herbal 0 6 8129 8135 O
supplements 7 18 8136 8147 I-treatment

history 0 7 8148 8155 O
of 8 10 8156 8158 O
documented 11 21 8159 8169 O
congestive 22 32 8170 8180 B-chronic_disease
heart 33 38 8181 8186 I-chronic_disease
failure 39 46 8187 8194 I-chronic_disease
( 47 48 8195 8196 O
New 48 51 8196 8199 B-clinical_variable
York 52 56 8200 8204 I-clinical_variable
Heart 57 62 8205 8210 I-clinical_variable
Association 63 74 8211 8222 I-clinical_variable
functional 75 85 8223 8233 O
classification 86 100 8234 8248 O
III 101 104 8249 8252 B-lower_bound
- 104 105 8252 8253 O
IV 105 107 8253 8255 B-upper_bound
) 107 108 8255 8256 O

known 0 5 8257 8262 O
severely 6 14 8263 8271 O
impaired 15 23 8272 8280 B-chronic_disease
lung 24 28 8281 8285 I-chronic_disease
function 29 37 8286 8294 I-chronic_disease
( 38 39 8295 8296 O
spirometry 39 49 8296 8306 B-treatment
and 50 53 8307 8310 O
carbon 54 60 8311 8317 B-clinical_variable
monoxide 61 69 8318 8326 I-clinical_variable
diffusing 70 79 8327 8336 I-clinical_variable
capacity 80 88 8337 8345 I-clinical_variable
[ 89 90 8346 8347 I-clinical_variable
DLCO 90 94 8347 8351 I-clinical_variable
] 94 95 8351 8352 I-clinical_variable
50 96 98 8353 8355 B-upper_bound
% 98 99 8355 8356 I-upper_bound
or 100 102 8357 8359 O
less 103 107 8360 8364 O
of 108 110 8365 8367 O
normal 111 117 8368 8374 O
and 118 121 8375 8378 O
oxygen 122 128 8379 8385 B-clinical_variable
[ 129 130 8386 8387 I-clinical_variable
O2 130 132 8387 8389 I-clinical_variable
] 132 133 8389 8390 I-clinical_variable
saturation 134 144 8391 8401 I-clinical_variable
88 145 147 8402 8404 B-upper_bound
% 147 148 8404 8405 I-upper_bound
or 149 151 8406 8408 O
less 152 156 8409 8413 O
at 157 159 8414 8416 O
rest 160 164 8417 8421 O
on 165 167 8422 8424 O
room 168 172 8425 8429 O
air 173 176 8430 8433 O
) 176 177 8433 8434 O

myocardial 0 10 8435 8445 B-chronic_disease
infarction 11 21 8446 8456 I-chronic_disease
within 22 28 8457 8463 O
6 29 30 8464 8465 B-upper_bound
months 31 37 8466 8472 I-upper_bound
prior 38 43 8473 8478 I-upper_bound
to 44 46 8479 8481 O
screening 47 56 8482 8491 O

no 0 2 8492 8494 O
evidence 3 11 8495 8503 O
of 12 14 8504 8506 O
new 15 18 8507 8510 O
or 19 21 8511 8513 O
enlarging 22 31 8514 8523 O
CNS 32 35 8524 8527 B-cancer
metastasis 36 46 8528 8538 I-cancer

nursing 0 7 8539 8546 O
( 8 9 8547 8548 O
lactating 9 18 8548 8557 O
) 18 19 8557 8558 O
women 20 25 8559 8564 B-gender

off 0 3 8565 8568 O
steroids 4 12 8569 8577 B-treatment

other 0 5 8578 8583 O
cardiac 6 13 8584 8591 O
arrhythmia 14 24 8592 8602 B-chronic_disease
not 25 28 8603 8606 O
controlled 29 39 8607 8617 O
with 40 44 8618 8622 O
medication 45 55 8623 8633 B-treatment

uncontrolled 0 12 8634 8646 O
hypertension 13 25 8647 8659 B-chronic_disease
defined 26 33 8660 8667 O
by 34 36 8668 8670 O
a 37 38 8671 8672 O
Systolic 39 47 8673 8681 B-clinical_variable
Blood 48 53 8682 8687 I-clinical_variable
Pressure 54 62 8688 8696 I-clinical_variable
( 63 64 8697 8698 I-clinical_variable
SBP 64 67 8698 8701 I-clinical_variable
) 67 68 8701 8702 I-clinical_variable
> 69 70 8703 8704 O
/= 70 72 8704 8706 O
160 73 76 8707 8710 B-lower_bound
mm 77 79 8711 8713 I-lower_bound
Hg 80 82 8714 8716 I-lower_bound
and/or 83 89 8717 8723 O
Diastolic 90 99 8724 8733 B-clinical_variable
Blood 100 105 8734 8739 I-clinical_variable
Pressure 106 114 8740 8748 I-clinical_variable
( 115 116 8749 8750 I-clinical_variable
DBP 116 119 8750 8753 I-clinical_variable
) 119 120 8753 8754 I-clinical_variable
> 121 122 8755 8756 O
/= 122 124 8756 8758 O
100 125 128 8759 8762 B-lower_bound
mm 129 131 8763 8765 I-lower_bound
Hg 132 134 8766 8768 I-lower_bound
, 134 135 8768 8769 O
with 136 140 8770 8774 O
or 141 143 8775 8777 O
without 144 151 8778 8785 O
antihypertensive 152 168 8786 8802 B-treatment
medication 169 179 8803 8813 O
- 180 181 8814 8815 O
initiation 182 192 8816 8826 O
or 193 195 8827 8829 O
adjustment 196 206 8830 8840 O
of 207 209 8841 8843 O
antihypertensive 210 226 8844 8860 B-treatment
medication(s 227 239 8861 8873 I-treatment
) 239 240 8873 8874 I-treatment
is 241 243 8875 8877 O
allowed 244 251 8878 8885 O
prior 252 257 8886 8891 O
to 258 260 8892 8894 O
screening 261 270 8895 8904 O

unstable 0 8 8905 8913 B-chronic_disease
angina 9 15 8914 8920 I-chronic_disease
within 16 22 8921 8927 O
6 23 24 8928 8929 B-upper_bound
months 25 31 8930 8936 I-upper_bound
prior 32 37 8937 8942 I-upper_bound
to 38 40 8943 8945 O
screening 41 50 8946 8955 O

ventricular 0 11 8956 8967 B-chronic_disease
arrhythmias 12 23 8968 8979 I-chronic_disease
; 23 24 8979 8980 O
supraventricular 25 41 8981 8997 B-chronic_disease
and 42 45 8998 9001 O
nodal 46 51 9002 9007 O
arrhythmias 52 63 9008 9019 O
not 64 67 9020 9023 O
controlled 68 78 9024 9034 O
with 79 83 9035 9039 O
medication 84 94 9040 9050 B-treatment

where 0 5 9051 9056 O
pregnancy 6 15 9057 9066 B-pregnancy
is 16 18 9067 9069 O
defined 19 26 9070 9077 O
as 27 29 9078 9080 O
the 30 33 9081 9084 O
state 34 39 9085 9090 O
of 40 42 9091 9093 O
a 43 44 9094 9095 O
female 45 51 9096 9102 B-gender
after 52 57 9103 9108 O
conception 58 68 9109 9119 O
and 69 72 9120 9123 O
until 73 78 9124 9129 O
the 79 82 9130 9133 O
termination 83 94 9134 9145 O
of 95 97 9146 9148 O
gestation 98 107 9149 9158 O
, 107 108 9158 9159 O
confirmed 109 118 9160 9169 O
by 119 121 9170 9172 O
a 122 123 9173 9174 O
positive 124 132 9175 9183 O
hCG 133 136 9184 9187 O
laboratory 137 147 9188 9198 O
test 148 152 9199 9203 O

